Status:
COMPLETED
Early Antiretroviral Therapy and Pre-exposure Prophylaxis for HIV Prevention Among Female Sex Workers in Cotonou, Benin
Lead Sponsor:
CHU de Quebec-Universite Laval
Collaborating Sponsors:
Bill and Melinda Gates Foundation
Gilead Sciences
Conditions:
Adherence to Medication Regime
Eligibility:
FEMALE
18+ years
Phase:
PHASE4
Brief Summary
In the last few years, early treatment of HIV-infected individuals, or "treatment as prevention (TasP), and pre-exposure prophylaxis with antiretroviral drugs among HIV-negative people at very high-ri...
Detailed Description
At the end of 2012, sub-Saharan Africa was home to 71% of the 35.3 million people living with HIV worldwide. Despite all the preventive and therapeutic efforts accomplished so far, the epidemic is per...
Eligibility Criteria
Inclusion
- TasP
- Being aged 18 years or more
- Being HIV-positive at screening and re-confirmed on a second sample
- Being HIV treatment naïve
Exclusion
- Women showing a compromised renal or liver function at clinical follow-up could be excluded anytime during the course of the study.
- PrEP
- Inclusion Criteria:
- Being aged 18 years or more
- Being HIV-negative at screening and re-confirmed at the recruitment visit
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2016
Estimated Enrollment :
361 Patients enrolled
Trial Details
Trial ID
NCT02237027
Start Date
October 1 2014
End Date
December 1 2016
Last Update
July 19 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dispensaire IST (DIST)
Cotonou, Benin